Compare TGL & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGL | VVOS |
|---|---|---|
| Founded | 2020 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 2.6M |
| IPO Year | 2022 | 2020 |
| Metric | TGL | VVOS |
|---|---|---|
| Price | $0.22 | $0.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.12 |
| AVG Volume (30 Days) | ★ 7.5M | 2.3M |
| Earning Date | 10-13-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.53 | 6.76 |
| EPS | N/A | ★ N/A |
| Revenue | $5,169,784.00 | ★ $17,443,000.00 |
| Revenue This Year | N/A | $24.92 |
| Revenue Next Year | N/A | $56.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 121.83 | 16.05 |
| 52 Week Low | $0.19 | $0.12 |
| 52 Week High | $587.80 | $3.05 |
| Indicator | TGL | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 24.14 | 36.52 |
| Support Level | $0.19 | $0.13 |
| Resistance Level | $3.30 | $0.55 |
| Average True Range (ATR) | 0.20 | 0.01 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 2.29 | 27.02 |
Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.